WTO
UTime Ltd

6,763
Loading...
Loading...
News
all
press releases
How Is The Market Feeling About UTime?
read more...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
Why UTime (WTO) Stock Is Down 17% Today
UTime shares are trading lower by 17% during Friday's session. The company announced a $5 million registered direct offering. read more...
Benzinga·1y ago
News Placeholder
Why Micro-cap WTO Stock's Retail Following Surged By Nearly 45% This Week
UTime's abrupt shift into the vaccine sector has raised eyebrows among investors, leading to a dramatic 93% decline in the stock price on Wednesday alone.
Stocktwits·1y ago
News Placeholder
UTime Shareholders Greenlight Major Corporate Reshuffle
UTime (WTO) has released an update. UTime Limited shareholders have overwhelmingly approved proposals for a share consolidation and an increase in...
TipRanks Financial Blog·1y ago
News Placeholder
What In The World Is Going On With UTime (WTO) Stock Today?
UTime shares have experienced extreme volatility this week, with a dramatic 93% drop on Wednesday. On Thursday, UTime's stock rebounded 48% to 13 cents after the company addressed recent...
Benzinga·1y ago
News Placeholder
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price Remarkable Announcement on Significant Fluctuation of the UTime's Share Price PR Newswire SHENZHEN, China, Aug. 29, 2024...
PR Newswire·1y ago
News Placeholder
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics PR Newswire SHENZHEN, China, Aug. 29, 2024 SHENZHEN...
PR Newswire·1y ago
News Placeholder
UTime (WTO) Stock Is Down 93% Today: What's Going On?
UTime shares are trading lower by 93% Wednesday afternoon. The company announced a non-disclosure agreement to acquire Bowen Therapeutics' lab at UMASS Medical School. read more...
Benzinga·1y ago
News Placeholder
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen...
PR Newswire·1y ago
News Placeholder
About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron
About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron About Circul VS: A Core Continuous Blood Pressure Measurement Technology...
PR Newswire·1y ago

Latest WTO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.